Tony Blairs Economic Blueprint Diagnosis on Point Prescription Under Fire
Trump Expresses Dissatisfaction with Iran Nuclear Deal Talks Heightening Geopolitical Uncertainty
Obsession Poised to Achieve Major Box Office Milestones This Weekend
Kevin Warsh Faces Divided Fed as Inflation Pressures Complicate Rate Cut Debate
April Private Payrolls Rise 109000 Exceeding Expectations ADP Report Signals Steady Labor Market
Alberta Separatist Vote Could Reshape Canadas Energy Landscape
DG Q1 2026 Earnings EPS Beats Estimates as Dollar General Surpasses Expectations
Dole Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed
UIS Q1 2026 Earnings Strong EPS Surprise as Unisys Posts SmallerthanExpected Loss
PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism
PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter
ENPH Q1 2026 Earnings EPS Surprises to the Upside as Enphase Navigates Market Headwinds
Day One Biopharmaceuticals DAWN Holds Steady Consolidation Near Support Tests
Blend Labs BLND Surges Over 10 as Momentum Builds Near Key Resistance
SolarEdge Technologies SEDG Surges 55 as Solar Sector Regains Lift
Warby Parker WRBY Pushes Higher as Eyewear Retailer Tests Key Resistance
BlackRock Science and Technology Trust BST Gains 231 as Tech Sentiment Lifts Prices
Liberty Live Group LLYVA Holds Steady Near 96 as Support and Resistance Levels Come into Focus
OneIM Acquisition Corp OIM Holds Steady at 1001 Low Volatility Signals Waiting Game
Copa Holdings CPA Holds Steady Near Support Amid Minimal Volatility
Core Scientific CORZ Gains 177 as Cryptocurrency Mining Sector Shows Renewed Momentum
Titan Acquisition Corp Warrants TACHW Edge Higher Support Holds as Price Approaches Key Resistance
Westin Acquisition Corp Units WSTNU Holds Steady at 1018 SPAC Units Show Minimal Daily Movement
US Natural Gas Futures Decline as Weather Forecasts Signal Milder Early February Temperatures
MDV Q1 2026 Earnings Industrial REIT Reports Deep Earnings Miss as Losses Sharply Exceed Estimates
Zymeworks Inc ZYME Faces Selling Pressure as Shares Dip 240 Key Levels in Focus